316 related articles for article (PubMed ID: 27600408)
21. Methods for the Analysis and Characterization of Defense Mechanisms Against Horizontal Gene Transfer: CRISPR Systems.
Calvo-Villamañán A; Bernheim A; Bikard D
Methods Mol Biol; 2020; 2075():235-249. PubMed ID: 31584167
[TBL] [Abstract][Full Text] [Related]
22. Predominance of Single Prophage Carrying a CRISPR/cas System in "Candidatus Liberibacter asiaticus" Strains in Southern China.
Zheng Z; Bao M; Wu F; Chen J; Deng X
PLoS One; 2016; 11(1):e0146422. PubMed ID: 26741827
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
Nayeemul Bari SM; Hatoum-Aslan A
Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
[TBL] [Abstract][Full Text] [Related]
24. Investigation of direct repeats, spacers and proteins associated with clustered regularly interspaced short palindromic repeat (CRISPR) system of Vibrio parahaemolyticus.
Baliga P; Shekar M; Venugopal MN
Mol Genet Genomics; 2019 Feb; 294(1):253-262. PubMed ID: 30357478
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9-based efficient genome editing in Staphylococcus aureus.
Liu Q; Jiang Y; Shao L; Yang P; Sun B; Yang S; Chen D
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):764-770. PubMed ID: 28910979
[TBL] [Abstract][Full Text] [Related]
26. Exploring the Interplay of the CRISPR-CAS System with Antibiotic Resistance in
Shabbir MAB; Ul-Rahman A; Iftikhar MR; Rasheed M; Maan MK; Sattar A; Ahmad M; Khan FA; Ahmad W; Riaz MI; Aslam HB
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256391
[No Abstract] [Full Text] [Related]
27. CRISPR-Cas Systems Optimize Their Immune Response by Specifying the Site of Spacer Integration.
McGinn J; Marraffini LA
Mol Cell; 2016 Nov; 64(3):616-623. PubMed ID: 27618488
[TBL] [Abstract][Full Text] [Related]
28. Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.
Briner AE; Lugli GA; Milani C; Duranti S; Turroni F; Gueimonde M; Margolles A; van Sinderen D; Ventura M; Barrangou R
PLoS One; 2015; 10(7):e0133661. PubMed ID: 26230606
[TBL] [Abstract][Full Text] [Related]
29. Genomic impact of CRISPR immunization against bacteriophages.
Barrangou R; Coûté-Monvoisin AC; Stahl B; Chavichvily I; Damange F; Romero DA; Boyaval P; Fremaux C; Horvath P
Biochem Soc Trans; 2013 Dec; 41(6):1383-91. PubMed ID: 24256225
[TBL] [Abstract][Full Text] [Related]
30. Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems.
Silas S; Lucas-Elio P; Jackson SA; Aroca-Crevillén A; Hansen LL; Fineran PC; Fire AZ; Sánchez-Amat A
Elife; 2017 Aug; 6():. PubMed ID: 28826484
[TBL] [Abstract][Full Text] [Related]
31. Analysis of Staphylococcal cassette chromosome mec in Staphylococcus haemolyticus and Staphylococcus sciuri: identification of a novel ccr gene complex with a newly identified ccrA allotype (ccrA7).
Urushibara N; Paul SK; Hossain MA; Kawaguchiya M; Kobayashi N
Microb Drug Resist; 2011 Jun; 17(2):291-7. PubMed ID: 21388304
[TBL] [Abstract][Full Text] [Related]
32. Pan genome and CRISPR analyses of the bacterial fish pathogen Moritella viscosa.
Karlsen C; Hjerde E; Klemetsen T; Willassen NP
BMC Genomics; 2017 Apr; 18(1):313. PubMed ID: 28427330
[TBL] [Abstract][Full Text] [Related]
33. Correlation between type IIIA CRISPR-Cas system and SCCmec in Staphylococcus epidermidis.
Zhu T; Zhao Y
Arch Microbiol; 2021 Dec; 203(10):6275-6286. PubMed ID: 34668031
[TBL] [Abstract][Full Text] [Related]
34. Tailor-made gene silencing of Staphylococcus aureus clinical isolates by CRISPR interference.
Sato'o Y; Hisatsune J; Yu L; Sakuma T; Yamamoto T; Sugai M
PLoS One; 2018; 13(1):e0185987. PubMed ID: 29377933
[TBL] [Abstract][Full Text] [Related]
35. CRISPR-Cas systems and RNA-guided interference.
Barrangou R
Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
[TBL] [Abstract][Full Text] [Related]
36. Role of CRISPR/cas system in the development of bacteriophage resistance.
Szczepankowska A
Adv Virus Res; 2012; 82():289-338. PubMed ID: 22420856
[TBL] [Abstract][Full Text] [Related]
37. A subset of Staphylococcus aureus strains harboring staphylococcal cassette chromosome mec (SCCmec) type IV is deficient in CcrAB-mediated SCCmec excision.
Noto MJ; Archer GL
Antimicrob Agents Chemother; 2006 Aug; 50(8):2782-8. PubMed ID: 16870772
[TBL] [Abstract][Full Text] [Related]
38. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
Steinert J; Schiml S; Fauser F; Puchta H
Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
[TBL] [Abstract][Full Text] [Related]
39. Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli.
Aydin S; Personne Y; Newire E; Laverick R; Russell O; Roberts AP; Enne VI
J Antimicrob Chemother; 2017 Aug; 72(8):2213-2218. PubMed ID: 28535195
[TBL] [Abstract][Full Text] [Related]
40. The origin of a methicillin-resistant Staphylococcus aureus isolate at a neonatal ward in Sweden-possible horizontal transfer of a staphylococcal cassette chromosome mec between methicillin-resistant Staphylococcus haemolyticus and Staphylococcus aureus.
Berglund C; Söderquist B
Clin Microbiol Infect; 2008 Nov; 14(11):1048-56. PubMed ID: 19040477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
